Jennifer L. S. Willoughby
Alnylam Pharmaceuticals (United States)
ORCID: 0000-0001-5239-4126Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested β papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 3 papers. Top paper: βTargeting the oncogene LSF with either the small molecule inhibitor FQI1 or siRNA causes mitotic delays with unaligned chromosomes, resulting in cell death or senescenceβ.
Kelly M. George, Mark P. Roberto, Hang Gyeong Chin, Patrick Stoiber, Hyunjin Shin +6 more
Jennifer L. S. Willoughby, Julian Kwan, Jessica M. Biagi, Niranjana Pokharel, Hang Gyeong Chin +8 more
Robert N. Helsley, Taghreed Fadhul, Jennifer L. S. Willoughby, Leila Noetzli, Ho-Chou Tu +18 more